NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000690

Registered date:01/11/2007

A randomized controlled trial of transcatheter arterial chemoembolization(TACE) in patients with advanced hepatocellular:Comparison of periodical TACE versus recurrence time TACE

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedadvanced hepatocellular carcinoma(HCC)
Date of first enrollment2007/05/01
Target sample size78
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)TACE was underwent when the recurrence of HCC was observed via follow-up dynamic CT or MRI. However, when no recurrence of HCC was observed, planned periodic TACE was repeated at 6 month intervals. TACE was repeated only when the recurrence of HCC was observed via follow-up dynamic CT or MRI.

Outcome(s)

Primary Outcomecumulative survival rate
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaa)patients with HCC suitable for curative treatment b)Child C c)allergy of contrast medium d)list of living donor liver transplantation e)portal vein tumor thrombus f)extrahepatic metastasis g)sponteneous tumor rupture h)The patients whom judged to be inadequate by clinical trial liability or clinical trial allotment doctor.

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail takuma@iwakuni-nh.go.jp
Affiliation National Hospital Organization Iwakuni Clinical Center Department of Clinical Research
scientific contact
Name Yoshitaka Takuma
Address 2-5-1 Kuroiso-cho, Iwakuni, Yamaguchi , Japan Japan
Telephone
E-mail
Affiliation National Hospital Organization Iwakuni Clinical Center Internal Medicine